Last reviewed · How we verify
SULFALOID (TRISULFAPYRIMIDINES (SULFADIAZINE)
SULFALOID (generic name: TRISULFAPYRIMIDINES (SULFADIAZINE) is a drug developed by FOREST PHARMS. It is currently FDA-approved.
SULFALOID is a small molecule inhibitor of bacterial dihydropteroate synthase, classified as an inhibitor. It is a synthetic compound with various synonyms, including ALTREET-AG, DERMAZIN, FLAMAZINE, FLAMMACERIUM, SILDAFLO, and SILVADENE.
At a glance
| Generic name | TRISULFAPYRIMIDINES (SULFADIAZINE |
|---|---|
| Sponsor | FOREST PHARMS |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SULFALOID CI brief — competitive landscape report
- SULFALOID updates RSS · CI watch RSS
- FOREST PHARMS portfolio CI
Frequently asked questions about SULFALOID
What is SULFALOID?
SULFALOID (TRISULFAPYRIMIDINES (SULFADIAZINE) is a pharmaceutical drug developed by FOREST PHARMS.
Who makes SULFALOID?
SULFALOID is developed and marketed by FOREST PHARMS (see full FOREST PHARMS pipeline at /company/forest-pharms).
What is the generic name of SULFALOID?
TRISULFAPYRIMIDINES (SULFADIAZINE is the generic (nonproprietary) name of SULFALOID.
What development phase is SULFALOID in?
SULFALOID is FDA-approved (marketed).
Related
- Manufacturer: FOREST PHARMS — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing